Correlating Patient-Reported Quality of Life before, during, and after Therapy with Objective Measures and Outcomes
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 5 July 2024 | Viewed by 22849
Special Issue Editors
Interests: patient safety/quality; head and neck
Special Issue Information
Dear Colleagues,
The incorporation of patient-reported outcomes (PRO) and quality of life (QOL) is standard practice in modern cancer clinical trials for any combination of surgery, chemotherapy, and/or radiation therapy. While these metrics were designed to characterize the patient’s experience of disease and treatment sequalae, a growing body of evidence suggests that PRO/QOL parameters can have prognostic implications.
Many validated instruments are currently in use. The correlation of these instruments with objective measures (such as imaging, biomarkers, patient functioning, and survival) is necessary to identify the optimal instrument(s) for each population.
In this Special Issue, we invite original manuscripts and review articles on all topics comparing PRO/QOL instruments, with an emphasis on correlations with objective measures such as imaging, biomarkers (immune function, markers of stress, etc.), patient functioning, and survival.
Prof. Dr. Anurag K. Singh
Dr. Evan Michael Graboyes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PRO
- QOL
- imaging
- physical functioning
- biomarkers
- immune
- survival
- surgery
- chemotherapy
- radiation